MS: Busting the Myths
June 22, 2023 | Advocacy, Funding, Media, Progressive
Multiple Sclerosis New Zealand (MSNZ) is delighted to share that Pharmac have commenced consultation to fund Ocrelizumab for Primary Progressive MS. Currently, those with PPMS have no access to any disease modifying therapies. Ocrelizumab has been proven in trials to […]
November 16, 2022 | Advocacy, Funding, Treatments
At the August 2022 meeting of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC), Multiple Sclerosis NZ (MSNZ) made a submission in support of the funding of Siponimod (Mayzent) for Secondary Progressive MS. At this meeting PTAC recommended listing with low priority and have requested further advice from the […]
August 8, 2022 | Funding, Grants, Life with MS, Scholarships
Last year I was the successful recipient of the Mastering Mountains Grant for people with FND and MS. My objective was to climb a 3,000m peak the Southern Alps. When I first submitted my application for the Grant I had […]
May 10, 2022 | Funding, Research, Study, Training
MSNZ is delighted with the announcement from the New Zealand MS Research Trust that they have received funding of NZ$150,000 a year for three years to support neurologists who wish to travel overseas to specialise in the treatment of people […]
March 9, 2022 | Funding
Join the Home of Brands Conscious Consumer Programme to help us raise funds. We’ve joined the Home of Brands Conscious Consumer Programme, with exclusive member access to 1000’s of discounted products and high quality retail brands to help us raise […]